Treating opioid addiction

Nosyk and colleagues[1][1] have analyzed data from the North American Opiate Medication Initiative (NAOMI)[2][2] in an attempt to ascertain cost-effectiveness of diacetylmorphine versus methadone among those “refractory to treatment” (people in whom “standard” methadone maintenance has